Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors

被引:10
作者
Chen, Xingye [1 ]
Liu, Haichun [1 ]
Xie, Wuchen [1 ]
Yang, Yan [1 ]
Wang, Yuchen [1 ]
Fan, Yuanrong [1 ]
Hua, Yi [1 ]
Zhu, Lu [1 ]
Zhao, Junnan [1 ]
Lu, Tao [1 ,2 ]
Chen, Yadong [1 ]
Zhang, Yanmin [1 ]
机构
[1] China Pharmaceut Univ, Sch Sci, Lab Mol Design & Drug Discovery, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR DOCKING; DRUG DESIGN; DISCOVERY; POTENT; DERIVATIVES; RECEPTOR; OPTIMIZATION; PERFORMANCE; ALGORITHM; TARGETS;
D O I
10.1021/acs.jcim.9b00684
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein kinases are important drug targets in several therapeutic areas,and structure-based virtual screening (SBVS) is an important strategy in discovering lead compounds for kinase targets. However, there are multiple crystal structures available for each target, and determining which one is the most favorable is a key step in molecular docking for SBVS due to the ligand induce-fit effect. This work aimed to find the most desirable crystal structures for molecular docking by a comprehensive analysis of the protein kinase database which covers 190 different kinases from all eight main kinase families. Through an integrated self-docking and cross-docking evaluation, 86 targets were eventually evaluated on a total of 2608 crystal structures. Results showed that molecular docking has great capability in reproducing conformation of crystallized ligands and for each target, the most favorable crystal structure was selected, and the AGC family outperformed the other family targets based on RMSD comparison. In addition, RMSD values, GlideScore, and corresponding bioactivity data were compared and demonstrated certain relationships. This work provides great convenience for researchers to directly select the optimal crystal structure in SBVS-based kinase drug design and further validates the effectiveness of molecular docking in drug discovery.
引用
收藏
页码:5244 / 5262
页数:19
相关论文
共 67 条
[1]   Current Insights of BRAF Inhibitors in Cancer [J].
Agianian, Bogos ;
Gavathiotis, Evripidis .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) :5775-5793
[2]   DOCK 6: Impact of New Features and Current Docking Performance [J].
Allen, William J. ;
Balius, Trent E. ;
Mukherjee, Sudipto ;
Brozell, Scott R. ;
Moustakas, Demetri T. ;
Lang, P. Therese ;
Case, David A. ;
Kuntz, Irwin D. ;
Rizzo, Robert C. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2015, 36 (15) :1132-1156
[3]   Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide [J].
Alogheli, Hiba ;
Olanders, Gustav ;
Schaal, Wesley ;
Brandt, Peter ;
Karlen, Anders .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (02) :190-202
[4]   Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors [J].
Ashwell, Mark A. ;
Lapierre, Jean-Marc ;
Brassard, Christopher ;
Bresciano, Karen ;
Bull, Cathy ;
Cornell-Kennon, Susan ;
Eathiraj, Sudharshan ;
France, Dennis S. ;
Hall, Terence ;
Hill, Jason ;
Kelleher, Eoin ;
Khanapurkar, Sampada ;
Kizer, Darin ;
Koerner, Steffi ;
Link, Jeff ;
Liu, Yanbin ;
Makhija, Sapna ;
Moussa, Magdi ;
Namdev, Nivedita ;
Khanh Nguyen ;
Nicewonger, Robert ;
Palma, Rocio ;
Szwaya, Jeff ;
Tandon, Manish ;
Uppalapati, Uma ;
Vensel, David ;
Volak, Laurie P. ;
Volckova, Erika ;
Westlund, Neil ;
Wu, Hui ;
Yang, Rui-Yang ;
Chan, Thomas C. K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) :5291-5310
[5]   Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery [J].
Bajusz, David ;
Ferenczy, Gyorgy G. ;
Keseru, Gyorgy M. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (20) :2235-2259
[6]   Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 Experiment [J].
Baumgartner, Matthew P. ;
Camacho, Carlos J. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (06) :1004-1012
[7]   Kinase-targeted cancer therapies: progress, challenges and future directions [J].
Bhullar, Khushwant S. ;
Orrego Lagaron, Naiara ;
McGowan, Eileen M. ;
Parmar, Indu ;
Jha, Amitabh ;
Hubbard, Basil P. ;
Rupasinghe, H. P. Vasantha .
MOLECULAR CANCER, 2018, 17
[8]   Receptor-based virtual screening protocol for drug discovery [J].
Cerqueira, Nuno M. F. S. A. ;
Gesto, Diana ;
Oliveira, Eduardo F. ;
Santos-Martins, Diogo ;
Bras, Natercia F. ;
Sousa, Sergio F. ;
Fernandes, Pedro A. ;
Ramos, Maria J. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 582 :56-67
[9]   Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree [J].
Chartier, Matthieu ;
Chenard, Thierry ;
Barker, Jonathan ;
Najmanovich, Rafael .
PEERJ, 2013, 1
[10]   Kinase Drug Discovery - What's Next in the Field? [J].
Cohen, Philip ;
Alessi, Dario R. .
ACS CHEMICAL BIOLOGY, 2013, 8 (01) :96-104